# Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1

> **NCT03560323** · PHASE1 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 41 (actual)

## Conditions studied

- Heart Failure
- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Beta-hydroxy-butyrate

## Key facts

- **NCT ID:** NCT03560323
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-07
- **Primary completion:** 2024-08-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2025-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03560323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03560323, "Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03560323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*